Myriad Genetics (MYGN) announced that the United States Patent and Trademark Office has issued two new patents that further advance Myriad’s ability to bring its tumor-informed, high-definition, ...
TD Cowen reinstated coverage on Tempus AI with a "Buy" rating and raised its price target to $74 after the health-tech ...
19hon MSN
Tempus AI (TEM) is soaring 13% today after investment bank TD Cowen reinstated coverage of the shares with a Buy rating. TEM ...
We recently published a list of Top 10 AI Stocks Trending On Wall Street. In this article, we are going to take a look at where Tempus AI, Inc.
The Plant and Animal Genomics conference recently held in San Diego showcased the ways that rapidly advancing technologies can be used in the crop and livestock sectors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback